Game Time: FDA Releases Review Timeline Goals Set By MDUFA V
This exclusive infographic shows new review timelines the FDA announced for FY 2023 now that MDUFA V has been ratified.
You may also be interested in...
Industry observers at RAPS Convergence in Montreal last week said the FDA’s agenda for 2024 is likely to include increased emphasis on MDUFA goals, enhanced cybersecurity requirements, the new QMSR, and more.
The first clearance from the US Food and Drug Administration for an over-the-counter fingertip pulse oximeter has gone to Masimo's MightySat Medical, which is now available at the company's website.
HHS publishes a new website and releases its essential and enhanced voluntary cybersecurity performance goals.